Tech Company Financing Transactions

Aerovance Funding Round

Aerovance closed a $32 million Series B funding round on 8/23/2004. Investors included Apax Partners, Burrill & Company and Lehman Brothers Venture Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

2929 7th St. 120
Berkeley, CA 94710
USA

Phone

(510) 549-5500

Website

www.aerovance.com

Email Address

[email protected]

Overview

Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing biotherapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Perry

        

Chief Medical Officer

Tunde Otulana

        

Chief Technical Officer

Robert Kuhn

        

Executive Vice President

David Happel

        

Browse more venture capital transactions:

Prev: 8/23/2004: Spotwave Wireless venture capital transaction
Next: 8/23/2004: July Systems venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary